This week on Dr. Greg Davis on Medicine the host talks with Dr. Jennifer Havens of UK Healthcare's Department of Behavioral Science and the Center for Drug and Alcohol Research. Dr. Havens talks about a dramatic rise in intravenous drug use in Appalachia and what can realistically be done to prevent it.
This week Dr. Greg talks with Dr. Roger Humphries, chair of the department of emergency medicine at UK Healthcare, and a lead investigator at UK of a study involving treatment of epileptic seizures in an emergency room setting.
As part of National Mental Health Awareness Month, Dr. Greg talks with Dr. Cathy Martin, a UK Healthcare Child and Adolescent psychiatrist about some proven methods to treat substance abuse issues in adolescent patients.
May is National Mental Health Awareness Month and Dr. Greg has the first in a two part series on adolescent mental health issues. His guest this week is Dr. Kelly Hill, director of UK Healthcare's Adolescent Behavioral Health.
This week Dr. Greg Davis addresses some confusion over a recent article in the Journal of the American Medical Association claiming that pathologists only agree 75% of the time when diagnosing breast cancer. He talks with two surgical pathologists at UK Healthcare who have a subspecialty interest in breast pathology: Dr. Luis Samayoa, and Dr. Rachel Stewart.
This week Dr. Greg has details on a now postponed Colon Cancer Prevention Fair at the Lyric Theatre where people can learn about the disease, the number two cancer killer, and receive a free take-home colon cancer screening kit. The Fayette County Health Department says the event will be rescheduled for later this month. March is National Colorectal Cancer Awareness Month.
Dr. Greg Davis talks with Dr. Jayakrishna Ambati, professor and vice chair of the Department of Ophthalmology & Visual Sciences at the University of Kentucky, and his colleague Dr. Ben Fowler about a landmark study published recently in the journal Science by an international group of scientists, led by Dr. Ambati, showing that HIV/AIDS drugs that have been used for the last 30 years could be repurposed to treat age-related macular degeneration (AMD), as well as other inflammatory disorders, because of a previously undiscovered intrinsic and inflammatory activity those drugs possess.